Proto-Teeth Migrate Along The Developing Jaw
Researchers have captured on video how teeth find their way to the right spot in the jaw to give you that winning grin.
University of California San Francisco
Give to UCSF
UCSF, Kaiser Permanente Study Identifies Genetic Susceptibility for Hernia
Researchers at UCSF and Kaiser Permanente have identified variations at four locations in the genome that underlie the risk of inguinal hernia.
More Men with Mustaches than Women In Top Spots at Medical Schools, Study Shows
A man with a mustache is more likely than a woman to lead a medical school department, according to a study published on Wednesday Dec. 16, 2015, in the British Medical Journal.
Diversity in Medical Research Is a Long Way Off, Study Shows
Despite Congressional mandates aimed at diversifying clinical research, little has changed in the last 30 years in both the numbers of studies that include minorities and the diversity of scientists being funded, according to a new analysis by researchers at UCSF.
Researchers Create Cellular “ORACLs” to Aid Drug Discovery
A team of researchers at UCSF has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool.
Most Popular Science Stories of 2015
These are the stories that engaged our visitors in 2015 – whether it was reading in-depth about brain rejuvenation, watching mesmerizing cells in motion on social media, or learning about the latest discoveries that could soon lead to new treatments.
Big Ideas in Health and Science for 2016
We asked experts across UCSF to identify what's ahead in how we approach research, what disease areas will see major advances, and where basic science will be translating into real treatments.
‘Purity’ Of Tumor Samples May Significantly Bias Genomic Analyses
A new study by UCSF scientists shows that the proportion of normal cells, especially immune cells, intermixed with cancerous cells in a given tissue sample may significantly skew the results of genetic analyses and other tests performed both by researchers and by physicians selecting precision therapies.
Early Study Links Mothers’ Education Level to Telomere Length in Newborns
A small study of new mothers suggests that not having graduated from high school may impact the likelihood of babies being born with shortened telomeres.
Illuminating Depression’s Circuitry
If depression is caused by flawed brain circuitry, it may be possible to shift that circuitry toward healthy neural processing instead. UCSF researchers hope to map and correct aberrant neural behavior to cure mood disorders.
Affordable Care Act Will Spur California Health Care Workforce to Develop New Leadership, Flexibility and People Skills
As health care shifts away from a fee-for-service model as a result of the ACA, health care workers in California will be called upon to develop new skills and fill new roles, according to a study led by UCSF researchers.
How an Approach Called ‘Shock and Kill’ Could Cure HIV
HIV can lurk for a lifetime in the body, so to truly cure patients, scientists are trying to find ways to target these HIV reservoirs in a strategy known as “shock and kill.”
$20M Grant from amfAR Funds Institute for HIV Cure Research
In a bid to end the worst epidemic in modern times, the Foundation for AIDS Research (amfAR) is funding an ambitious effort based in San Francisco to eliminate the human immunodeficiency virus (HIV) from those who are infected.
Swaziland Likely To Be First To Eliminate Malaria In Southern Africa
The Malaria Elimination Group, an independent international advisory group on malaria elimination convened by the Global Health Group at the University of California, San Francisco (UCSF), gathered in the Ezulwini Valley for its tenth meeting to celebrate Swaziland’s achievements. The meeting was opened on November 16, 2015 by Swaziland’s Minister of Health, Honorable Sibongile Ndlela-Simelane.
Immunotherapy For Type 1 Diabetes Deemed Safe In First U.S. Trial
In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes, patients experienced no serious adverse reactions after receiving infusions of as many as 2.6 billion cells that had been specially selected to protect the body’s ability to produce insulin.